Events & Presentations
Featured Event
Upcoming Events
Presentations
| Date | Title |
|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add Links to Pages
|
|
|
|
|
|
|
Archived Events
| Date | Event Details |
|---|---|
| Summary Toggle Feb 11, 2020 3:00 PM GMT |
3rd Global NASH Congress 2020LocationLondon Heathrow Marriott
Speaker
Harold
H.
Shlevin,
PhD
President and chief executive officer
|
| Summary Toggle Dec 4, 2019 9:30 AM EST |
Corporate Update |
| Summary Toggle Apr 9, 2019 5:30 AM EDT |
2019 H.C. Wainwright Global Life Sciences Conference |
| Summary Toggle Sep 6, 2018 9:35 AM EDT |
H.C. Wainwright 20th Annual Global Investment Conference |
| Summary Toggle Apr 14, 2018 4:00 PM CEST |
The International Liver CongressTM 2018, European Association for the Study of the Liver (EASL) |
| Summary Toggle Apr 9, 2018 7:45 AM EDT |
H.C. Wainwright Global Life Sciences Conference |
| Summary Toggle Mar 19, 2018 4:00 PM EDT |
2nd Annual H.C. Wainwright NASH Investor Conference. New York, NY
Presentation 1.6 MB
|
| Summary Toggle Mar 19, 2018 4:00 PM JST |
Bio Asia, Tokyo, Japan |
| Summary Toggle Mar 17, 2018 8:30 AM HKT |
CHIPS, Hangzhou, China |
| Summary Toggle Mar 12, 2018 2:00 PM PDT |
30th Annual ROTH Conference |
| Summary Toggle Feb 13, 2018 10:15 AM EST |
Galectin Therapeutics at BIO CEO & Investor ConferenceLocationNew York Marriott Marquis , New York City
|
| Summary Toggle Dec 14, 2017 9:00 AM EST |
Galectin Therapeutics 2017 Annual Meeting of Shareholders - Corporate UpdateWebcast to begin at approximately 9 a.m. ET on Thursday, December 14, 2017 The webcast may be accessed directly via the following link:
The presentation may also be heard via teleconference by dialing 866.225.1342 (within the United States). A list of international dial-in numbers can be found here. The passcode for participants is 2856445641. Please dial-in or log-in approximately 10 minutes before the event begins to ensure a timely connection. |
| Summary Toggle Dec 5, 2017 8:30 AM EST |
Galectin Therapeutics Phase 2b NASH-CX Trial Results PresentationLive Dial-in: 888-317-6003
Pin #: 3493752 Replay Dial-in: 877-344-7529 Pin #: 10114808 |
| Summary Toggle Sep 12, 2017 11:40 AM EDT |
Galectin Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference |
| Summary Toggle Jul 13, 2017 3:30 PM EDT |
Singular Research Summer Conference |
| Summary Toggle Mar 15, 2017 11:30 AM PDT |
29th Annual ROTH Conference
Presentation 2.1 MB
|
| Summary Toggle Feb 13, 2017 3:00 PM EST |
BIO CEO & Investor Conference Webcast Presentation
Presentation 2.2 MB
|
| Summary Toggle Feb 2, 2017 11:30 AM EST |
VirtualInvestorConferences.com
Presentation 1.6 MB
|
| Summary Toggle Dec 15, 2016 1:30 PM EST |
Galectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update WebcastGalectin Therapeutics 2016 Annual Meeting of Stockholders - Corporate Update Webcast to begin at approximately 1:30 p.m. ET on Thursday, December 15, 2016 The webcast may be accessed directly via the following link: https://dentons.adobeconnect.com/galt_board/ The presentation may also be heard via teleconference by dialing 866-225-1342 (within the United States). A list of international dial-in numbers can be found here: https://www.tcconline.com/listNumbersByCode.action?confCode=8620018752 The passcode for participants is 8620018752 Please log in approximately 10 minutes before the event to ensure a timely connection. |
| Summary Toggle Sep 27, 2016 5:30 PM EDT |
Business Update Conference Call & Webcast
Transcript 94 KB
Participant dial-in number: 1-888-317-6003 |
| Summary Toggle Sep 12, 2016 3:50 PM EDT |
Rodman & Renshaw 18th Annual Global Investment Conference |
| Summary Toggle May 21, 2015 12:00 AM EDT |
2015 Annual Stockholder MeetingGalectin Therapeutics (Nasdaq:GALT) hosted a corporate update webcast on Thursday, May 21, 2015, immediately following the business portion of the Company’s Annual Meeting of Stockholders. Peter Traber, M.D., president, chief executive officer and chief medical officer discussed the company’s pipeline of galectin inhibitor compounds and progress in development of treatments for liver fibrosis and cancer. View the video replay: http://galectintherapeutics.com/stockholder-meeting-webcast/ |
| Summary Toggle May 14, 2014 10:00 AM EDT |
2014 Annual Stockholder MeetingGalectin Therapeutics (NASDAQ: GALT) held a webcast to provide an update following the Company's Annual Meeting of Shareholders. To view a PDF of the document referenced in the webcast, click here. |